196 related articles for article (PubMed ID: 31560956)
1. The Lord of the Lungs: The essential role of pulmonary surfactant upon inhalation of nanoparticles.
Garcia-Mouton C; Hidalgo A; Cruz A; Pérez-Gil J
Eur J Pharm Biopharm; 2019 Nov; 144():230-243. PubMed ID: 31560956
[TBL] [Abstract][Full Text] [Related]
2. Barrier or carrier? Pulmonary surfactant and drug delivery.
Hidalgo A; Cruz A; Pérez-Gil J
Eur J Pharm Biopharm; 2015 Sep; 95(Pt A):117-27. PubMed ID: 25709061
[TBL] [Abstract][Full Text] [Related]
3. The influence of pulmonary surfactant on nanoparticulate drug delivery systems.
Schleh C; Rothen-Rutishauser B; Kreyling WG
Eur J Pharm Biopharm; 2011 Apr; 77(3):350-2. PubMed ID: 21195761
[TBL] [Abstract][Full Text] [Related]
4. Physicochemical properties of nanoparticles regulate translocation across pulmonary surfactant monolayer and formation of lipoprotein corona.
Hu G; Jiao B; Shi X; Valle RP; Fan Q; Zuo YY
ACS Nano; 2013 Dec; 7(12):10525-33. PubMed ID: 24266809
[TBL] [Abstract][Full Text] [Related]
5. Pulmonary surfactant and nanocarriers: Toxicity versus combined nanomedical applications.
Hidalgo A; Cruz A; Pérez-Gil J
Biochim Biophys Acta Biomembr; 2017 Sep; 1859(9 Pt B):1740-1748. PubMed ID: 28450046
[TBL] [Abstract][Full Text] [Related]
6. Can nanotechnology hit the spot in aerosol-based drug delivery for lung disorders?
Joshi N
Ther Deliv; 2018 Mar; 9(4):233-236. PubMed ID: 29495926
[No Abstract] [Full Text] [Related]
7. Analysis of pulmonary surfactant in rat lungs after inhalation of nanomaterials: Fullerenes, nickel oxide and multi-walled carbon nanotubes.
Kadoya C; Lee BW; Ogami A; Oyabu T; Nishi K; Yamamoto M; Todoroki M; Morimoto Y; Tanaka I; Myojo T
Nanotoxicology; 2016; 10(2):194-203. PubMed ID: 25950198
[TBL] [Abstract][Full Text] [Related]
8. Physicochemical properties of nanoparticles affecting their fate and the physiological function of pulmonary surfactants.
Liu Q; Guan J; Song R; Zhang X; Mao S
Acta Biomater; 2022 Mar; 140():76-87. PubMed ID: 34843949
[TBL] [Abstract][Full Text] [Related]
9. Biophysical influence of airborne carbon nanomaterials on natural pulmonary surfactant.
Valle RP; Wu T; Zuo YY
ACS Nano; 2015 May; 9(5):5413-21. PubMed ID: 25929264
[TBL] [Abstract][Full Text] [Related]
10. Effects of nanoparticles on the mechanical functioning of the lung.
Arick DQ; Choi YH; Kim HC; Won YY
Adv Colloid Interface Sci; 2015 Nov; 225():218-28. PubMed ID: 26494653
[TBL] [Abstract][Full Text] [Related]
11. Pulmonary surfactant and drug delivery: Focusing on the role of surfactant proteins.
Guagliardo R; Pérez-Gil J; De Smedt S; Raemdonck K
J Control Release; 2018 Dec; 291():116-126. PubMed ID: 30321577
[TBL] [Abstract][Full Text] [Related]
12. Interaction Between Hydrophobic Au Nanoparticles and Pulmonary Surfactant (DPPC) Monolayers.
Zhang K; Liu L; Bai T; Guo Z
J Biomed Nanotechnol; 2018 Mar; 14(3):526-535. PubMed ID: 29663924
[TBL] [Abstract][Full Text] [Related]
13. Are Plant-Based Carbohydrate Nanoparticles Safe for Inhalation? Investigating Their Interactions with the Pulmonary Surfactant Using Langmuir Monolayers.
Gravel-Tatta L; DeWolf C; Badia A
Langmuir; 2021 Oct; 37(42):12365-12376. PubMed ID: 34644076
[TBL] [Abstract][Full Text] [Related]
14. Interaction of nano carbon particles and anthracene with pulmonary surfactant: The potential hazards of inhaled nanoparticles.
Zhao Q; Li Y; Chai X; Zhang L; Xu L; Huang J; Ning P; Tian S
Chemosphere; 2019 Jan; 215():746-752. PubMed ID: 30352372
[TBL] [Abstract][Full Text] [Related]
15. Understanding the mutual impact of interaction between hydrophobic nanoparticles and pulmonary surfactant monolayer.
Sachan AK; Galla HJ
Small; 2014 Mar; 10(6):1069-75. PubMed ID: 24339125
[TBL] [Abstract][Full Text] [Related]
16. Effect of clay nanoparticles on model lung surfactant: a potential marker of hazard from nanoaerosol inhalation.
Kondej D; Sosnowski TR
Environ Sci Pollut Res Int; 2016 Mar; 23(5):4660-9. PubMed ID: 26527341
[TBL] [Abstract][Full Text] [Related]
17. Protein-lipid interactions and surface activity in the pulmonary surfactant system.
Serrano AG; Pérez-Gil J
Chem Phys Lipids; 2006 Jun; 141(1-2):105-18. PubMed ID: 16600200
[TBL] [Abstract][Full Text] [Related]
18. Nanoparticles in the lung and their protein corona: the few proteins that count.
Whitwell H; Mackay RM; Elgy C; Morgan C; Griffiths M; Clark H; Skipp P; Madsen J
Nanotoxicology; 2016 Nov; 10(9):1385-94. PubMed ID: 27465202
[TBL] [Abstract][Full Text] [Related]
19. Effect of ions on the interactions of glass nanoparticles with monolayer lung surfactant: applications for the study of inhaled airborne wear particles.
Munteanu B; Berthier Y; Rieu JP; Sfarghiu AM
Comput Methods Biomech Biomed Engin; 2013; 16 Suppl 1():264-5. PubMed ID: 23923935
[No Abstract] [Full Text] [Related]
20. Influence of agglomeration and specific lung lining lipid/protein interaction on short-term inhalation toxicity.
Wohlleben W; Driessen MD; Raesch S; Schaefer UF; Schulze C; Vacano Bv; Vennemann A; Wiemann M; Ruge CA; Platsch H; Mues S; Ossig R; Tomm JM; Schnekenburger J; Kuhlbusch TA; Luch A; Lehr CM; Haase A
Nanotoxicology; 2016 Sep; 10(7):970-80. PubMed ID: 26984182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
